In addition to EZH2 knockdown, we also tested the effects of EZH2 inhibitor DZNep treatment on miR-200b promoter activity and miR-200b target reporter activity in MPNST cells. Here, EZH2 is linked to malignant peripheral nerve sheath tumor.